Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
46,698,782
-
Shares change
-
-1,526,815
-
Total reported value, excl. options
-
$2,789,816,513
-
Value change
-
-$86,471,529
-
Put/Call ratio
-
5.9%
-
Number of buys
-
91
-
Number of sells
-
-160
-
Price
-
$59.74
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2014
288 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2014.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,698,782 shares
of 50,495,188 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3,869,964 shares), WELLINGTON MANAGEMENT CO LLP (3,427,387 shares), ARIEL INVESTMENTS, LLC (1,996,270 shares), ACADIAN ASSET MANAGEMENT LLC (1,805,145 shares), Invesco Ltd. (1,739,841 shares), PRIMECAP MANAGEMENT CO/CA/ (1,692,800 shares), Fairpointe Capital LLC (1,680,916 shares), BlackRock Fund Advisors (1,391,974 shares), BlackRock Institutional Trust Company, N.A. (1,326,978 shares), and State Street Corp (1,318,284 shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.